During a White House press event led by President Donald Trump on obesity drug price reductions, Novo Nordisk executive Gordon Findlay suddenly collapsed. The incident occurred during the “Most Favoured Nations” Oval Office announcement on Thursday.
Witnesses reported that President Trump and attending officials immediately went to assist Findlay. The White House Medical Unit promptly provided medical attention, after which Findlay was confirmed to be in stable condition.
“During the Most Favoured Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly,” said Press Secretary Karoline Leavitt.
The event gathered senior pharmaceutical executives and administration officials. Companies Eli Lilly and Novo Nordisk announced a new agreement to lower the cost of their GLP-1 based weight-loss medications, offering them at significantly reduced prices.
Kushal Deb, a journalist with seven years of experience and a background in economics and policy, reported the event. His work focuses on research-driven storytelling and major public policy developments.
Author’s summary: A Novo Nordisk executive fainted during President Trump’s announcement on obesity drug price cuts, prompting a swift response from the White House medical team.